Akorn Hit With FDA Warning For Decatur Site In US

Akorn has again been pulled up by the FDA for deficiencies at its US manufacturing plant in Decatur, Illinois, concerning aseptic practices and cleaning procedures. Last year, the firm was issued a Form 483 inspection report for the site; now, it has been struck with an FDA warning letter.

Laboratory
Akorn gets warning letter after audit at Decatur site • Source: Shutterstock

More from Manufacturing

More from Business